SCHEMBL6602

SCHEMBL6602

Cc1noc(-c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3)cc2)c1CC(=O)NCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.49
ABCC3 O15438 1/20 0.49
ABCC4 O15439 1/20 0.49
ABCB11 O95342 1/20 0.49
CYP2C8 P10632 1/20 0.49
ABCB4 P21439 1/20 0.49
LPAR1 Q92633 1/20 0.49
ABCC2 Q92887 1/20 0.49
SLCO1B3 Q9NPD5 1/20 0.49
SLCO1B1 Q9Y6L6 1/20 0.49
AKR1C3 P42330 5/20 0.41
FAAH O00519 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TAS2R8 Q9NYW2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287 0.92 CYP2C9 (0.49) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6650 0.90 KCNA3 (0.43) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL6670 0.87 LPAR1 (0.51) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1951 0.87 LPAR1 (0.51) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1710 0.85 LPAR1 (0.49) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL1043 0.85 LPAR1 (0.52) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7264 0.85 CYP2C9 (0.49) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7014 0.85 TSHR (0.51) CYP2C9ABCC3ABCC4ABCB11CYP2C8
SCHEMBL7106 0.83 P2RX7 (0.46) CYP2C9AKR1C3FAAHCYP1A2CYP2D6
SCHEMBL5995 0.83 LPAR1 (0.61) CYP2C9ABCC3ABCC4ABCB11CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP claimed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO claimed
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed